Bronchial Sleeve Resection After Induction Therapy: Roll Up Your Sleeves

Abstract

Current guidelines recommend chemotherapy with or without radiotherapy for induction therapy in selected patients with stage IIIA non-small cell lung cancer (NSCLC).1 However national practice patterns vary with strong institutional preference for either neoadjuvant chemotherapy or neoadjuvant chemoradiation (NCR). A challenging subset of patients with locally advanced NSCLC are those likely to require complex resection and reconstruction or pneumonectomy. Because of significant short-term and long-term advantages, sleeve resection is preferred over pneumonectomy when possible.